Counterpoint Mutual Funds’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.45M Buy
42,485
+10,528
+33% +$2.45M 0.82% 29
2026
Q2
$7.59M Buy
+31,957
New +$6.64M 0.75% 23
2025
Q4
– Sell
-17,251
Closed -$2.71M – 374
2025
Q3
$2.71M Buy
17,251
+5,877
+52% +$908K 0.21% 33
2025
Q2
$1.91M Buy
+11,374
New +$1.69M 0.17% 46
2025
Q1
– Sell
-9,226
Closed -$1.09M – 299
2024
Q4
$1.09M Buy
9,226
+2,250
+32% +$263K 0.14% 48
2024
Q3
$771K Sell
6,976
-1,447
-17% -$151K 0.15% 55
2024
Q2
$828K Buy
8,423
+4,910
+140% +$500K 0.19% 35
2024
Q1
$393K Sell
3,513
-147
-4% -$15.9K 0.1% 54
2023
Q4
$369K Buy
3,660
+2,204
+151% +$219K 0.14% 17
2023
Q3
$126K Buy
+1,456
New +$132K 0.11% 150

Other funds holding CAH

Counterpoint Mutual Funds's CAH Position: Q3 2026 in Review

Counterpoint Mutual Funds increased its Cardinal Health (CAH) stake by 33% in Q3 2026, buying an estimated $2.45M and bringing the position to 42,485 shares worth $9.45M. The position accounts for 0.82% of the portfolio, ranked #29.

Counterpoint Mutual Funds first reported a position in CAH in Q3 2023 and has held it in 10 quarters since. 952 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Counterpoint Mutual Funds held 42,485 shares of Cardinal Health worth $9.45M as of Q3 2026.
  • Counterpoint Mutual Funds bought 10,528 Cardinal Health shares in Q3 2026, an estimated $2.45M.
  • Cardinal Health made up 0.82% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #29 holding.
  • Counterpoint Mutual Funds first reported a position in Cardinal Health in Q3 2023 and has held it in 10 quarters since.
  • 952 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.